Global HLA Typing Transplant Market Growth (Status and Outlook) 2023-2029

Global HLA Typing Transplant Market Growth (Status and Outlook) 2023-2029

Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. HLA are proteins -- or markers -- found on most cells in your body. Your immune system uses these markers to recognize which cells belong in your body and which do not.

LPI (LP Information)' newest research report, the “HLA Typing Transplant Industry Forecast” looks at past sales and reviews total world HLA Typing Transplant sales in 2022, providing a comprehensive analysis by region and market sector of projected HLA Typing Transplant sales for 2023 through 2029. With HLA Typing Transplant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HLA Typing Transplant industry.

This Insight Report provides a comprehensive analysis of the global HLA Typing Transplant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HLA Typing Transplant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HLA Typing Transplant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HLA Typing Transplant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HLA Typing Transplant.

The global HLA Typing Transplant market size is projected to grow from US$ 663.5 million in 2022 to US$ 944.7 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.

Technological advancements in organ transplantation are one of the primary drivers for market growth. New and improved transplantation products such as tissue-based products like organ preservation solution for particular organs, tissue typing technology (HLA typing), and surgical medical instruments drives the growth of the market. Moreover, the advancements in polymerase chain reaction (PCR) include enhancements in system design and advanced assay development, offering high accuracy, and efficiency in tissue typing. Also, the improvements in transplant technologies enhance patient safety and help keep track of organ functioning.

This report presents a comprehensive overview, market shares, and growth opportunities of HLA Typing Transplant market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Non-Molecular Assays
Molecular Assays

Segmentation by application
Hospitals
Academic and Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Immucor
Illumina
Thermo Fisher Scientific
Biofortuna
Bio-Rad Laboratories
GenDx
HistoGenetics
InGen
Linkage Biosciences
Omixon
Pacific Biosciences of California

Please note: The report will take approximately 2 business days to prepare and deliver.